<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1DD10A0C-161C-41BD-8C2D-AD8FF538CCBF"><gtr:id>1DD10A0C-161C-41BD-8C2D-AD8FF538CCBF</gtr:id><gtr:name>Perinatal Ireland</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DA520CA9-17B1-4166-A89C-915E6A74BFE3"><gtr:id>DA520CA9-17B1-4166-A89C-915E6A74BFE3</gtr:id><gtr:name>Norwegian Institute of Public Health</gtr:name><gtr:address><gtr:line1>Norwegian Institute of Public Health</gtr:line1><gtr:line2>PO Box 4404 Nydalen</gtr:line2><gtr:postCode>N-0403</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1DD10A0C-161C-41BD-8C2D-AD8FF538CCBF"><gtr:id>1DD10A0C-161C-41BD-8C2D-AD8FF538CCBF</gtr:id><gtr:name>Perinatal Ireland</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DA520CA9-17B1-4166-A89C-915E6A74BFE3"><gtr:id>DA520CA9-17B1-4166-A89C-915E6A74BFE3</gtr:id><gtr:name>Norwegian Institute of Public Health</gtr:name><gtr:address><gtr:line1>Norwegian Institute of Public Health</gtr:line1><gtr:line2>PO Box 4404 Nydalen</gtr:line2><gtr:postCode>N-0403</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3790EBA5-2C59-4BD3-983B-FECBD02A3B18"><gtr:id>3790EBA5-2C59-4BD3-983B-FECBD02A3B18</gtr:id><gtr:firstName>Jane</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Norman</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_G1002463"><gtr:id>26A8D019-FBDA-483E-B6D8-238E1D8B299A</gtr:id><gtr:title>Does metformin reduce excess birthweight in offspring of obese pregnant women?</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_G1002463</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Scientific Abstract|AIM: The aim of this study is to determine if metformin, administered to obese women during pregnancy, reduces the future life risk of obesity and metabolic syndrome in their babies. We will use high birthweight centile as a surrogate marker for future life events as its validity has been shown in large epidemiological studies [1-3]. Secondly, we will use metformin administration as a tool to explore the mechanism by which obesity causes adverse pregnancy outcomes, with a particular focus on insulin resistance (IR). |DESIGN: Double blind placebo controlled randomised clinical trial. |SETTING: Antenatal clinics specialising in the care of obese pregnant women in two large maternity hospitals in the UK (Edinburgh and Liverpool). |TARGET POPULATION: Obese pregnant women.|INTERVENTIONS BEING EVALUATED: Metformin, an insulin sensitising agent or matched placebo initiated between 12 and 16 weeks gestation. |PRIMARY OUTCOMES: (i) Efficacy outcome - z-score corresponding to the gestational age and sex adjusted birthweight centiles of the baby (ii) Mechanistic outcome - maternal insulin resistance (IR) at 36 weeks gestation which will be correlated with adverse pregnancy outcomes. |SECONDARY OUTCOMES: (A) More detailed measurements of neonatal body composition at birth including ponderal index; skinfold thicknesses; and (Edinburgh babies only) neonatal fat mass measured using air displacement plethysmography. (B) Biological mechanisms of metformin action including (i) change in IR; hepatic and skeletal insulin sensitivity (ii) maternal and neonatal inflammatory and lipid indices including CRP, IL-6, leptin, lipids, triglycerides and PAI1/PAI2 ratio (iii) placental glucocorticoid receptor expression (iv) maternal brachial arterial endothelial dependent flow mediated dilatation (FMD) (v) in vitro measurements of maternal myometrial contractility [4] (vi) changes in maternal anthrometry. (C) Adverse pregnancy outcomes as a composite; incidence of low birthweight centile. (D) Gas chromatography mass spectrometry measurements of metformin in maternal plasma to determine compliance.|MEASUREMENT OF OUTCOME AND DURATION OF FOLLOW UP. Birthweight will be measured by clinical staff, the result prospectively transferred from the clinical birth record to a case report form and Z score of birthweight centile calculated using www.gestation.net. Maternal IR at 36 weeks gestation will be expressed as the Matsuda index [5] (the best correlate with the gold standard the hyperinsulinaemic euglycaemic clamp in pregnant women)[6], and derived from multiple sampling during a glucose tolerance test. Change in IR will be expressed as changes in a logarithmic and reciprocal transformation of a single fasting glucose and insulin value (QUICKI), measured during a glucose tolerance test at baseline (prior to treatment), at 28 weeks and at 36 weeks gestation [6]. |In a subgroup of women (n = 20 in each group) insulin resistance will be measured by the hyperinsulinaemic euglycaemic clamp, to characterise the relative effects of metformin on hepatic and peripheral skeletal muscle insulin sensitivity. Endothelial dependent FMD will be measured in a subset (n = 30 each group) at 36 weeks gestation using a non invasive, validated, and reproducible method suitable for use in pregnancy [7 8]. Initial follow up will cease once the woman and baby have been discharged postnatally, although we anticipate further funding applications to continue neonatal follow up into early childhood.|SAMPLE SIZE: |(1) BIRTHWEIGHT CENTILE. In a previous study, the mean (SD) birthweight in a cohort of obese women (mean BMI 34) was 4.0kg (0.6kg)[9]. We hypothesise that metformin will reduce mean birthweight by 200g, corresponding to a reduction in birthweight centile of 0.3 SD. We believe that this reduction in birthweight centile is clinically relevant, but is a relatively conservative estimate of likely reduction in birthweight centile induced by metformin, given that m</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>996074</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Exeter</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Obstetrics &amp; Gynaecology</gtr:department><gtr:description>Collaborative group for STOPPIT 2 study</gtr:description><gtr:id>9C6FE0E3-D7A7-4F33-A357-555D86E5425E</gtr:id><gtr:impact>Grant application not yet funded. 
Multidisciplinary:
obstetrics
statistics</gtr:impact><gtr:outcomeId>C4AjVnHRsGg-5</gtr:outcomeId><gtr:partnerContribution>Members of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:partnerContribution><gtr:piContribution>Leadership of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Obstetrics and Gynaecology Research</gtr:department><gtr:description>Collaborative group for STOPPIT 2 study</gtr:description><gtr:id>F79F6542-8D08-4298-84EF-612A0F9D4A6B</gtr:id><gtr:impact>Grant application not yet funded. 
Multidisciplinary:
obstetrics
statistics</gtr:impact><gtr:outcomeId>C4AjVnHRsGg-2</gtr:outcomeId><gtr:partnerContribution>Members of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:partnerContribution><gtr:piContribution>Leadership of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Perinatal Ireland</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Scottish and Irish collaboration for stillbirth prevention study</gtr:description><gtr:id>7D092F75-EE79-4B98-AB85-E95EE3B4A24F</gtr:id><gtr:impact>Multidisciplinary grant application - obstetrics, midwifery, statistics, sociology</gtr:impact><gtr:outcomeId>CRx85zm7nTe-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input</gtr:partnerContribution><gtr:piContribution>I initiated this collaboration to generate a proposal and later funding for a stillbirth prevention study</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine &amp; Dentistry Aberdeen</gtr:department><gtr:description>Collaboration between MD and PF</gtr:description><gtr:id>529ECFF4-0E9E-4BA0-86D4-3DA96CF29B64</gtr:id><gtr:impact>PMID 21752894</gtr:impact><gtr:outcomeId>gLT2qhPtJpg-1</gtr:outcomeId><gtr:partnerContribution>intellectual input</gtr:partnerContribution><gtr:piContribution>intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>Collaborative group for STOPPIT 2 study</gtr:description><gtr:id>D5DA0579-2AC0-4AC4-99A6-4A4723BF724D</gtr:id><gtr:impact>Grant application not yet funded. 
Multidisciplinary:
obstetrics
statistics</gtr:impact><gtr:outcomeId>C4AjVnHRsGg-1</gtr:outcomeId><gtr:partnerContribution>Members of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:partnerContribution><gtr:piContribution>Leadership of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Obstetrics</gtr:department><gtr:description>Scottish and Irish collaboration for stillbirth prevention study</gtr:description><gtr:id>1A4D85DA-0544-4BE3-9EE9-4D32FA20ABFE</gtr:id><gtr:impact>Multidisciplinary grant application - obstetrics, midwifery, statistics, sociology</gtr:impact><gtr:outcomeId>CRx85zm7nTe-2</gtr:outcomeId><gtr:partnerContribution>Intellectual input</gtr:partnerContribution><gtr:piContribution>I initiated this collaboration to generate a proposal and later funding for a stillbirth prevention study</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Obstetrics and Gynaecology</gtr:department><gtr:description>Collaborative group for STOPPIT 2 study</gtr:description><gtr:id>29F90E76-B54C-4BBD-8EAF-D81418F6898A</gtr:id><gtr:impact>Grant application not yet funded. 
Multidisciplinary:
obstetrics
statistics</gtr:impact><gtr:outcomeId>C4AjVnHRsGg-4</gtr:outcomeId><gtr:partnerContribution>Members of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:partnerContribution><gtr:piContribution>Leadership of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Healthcare Randomised Trials</gtr:department><gtr:description>Collaborative group for STOPPIT 2 study</gtr:description><gtr:id>5AD0918D-C8FB-4D96-9F93-BAE4B8CDD8DB</gtr:id><gtr:impact>Grant application not yet funded. 
Multidisciplinary:
obstetrics
statistics</gtr:impact><gtr:outcomeId>C4AjVnHRsGg-3</gtr:outcomeId><gtr:partnerContribution>Members of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:partnerContribution><gtr:piContribution>Leadership of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Norwegian Institute of Public Health</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Department of International Public Health</gtr:department><gtr:description>Scottish and Irish collaboration for stillbirth prevention study</gtr:description><gtr:id>BA380411-8664-48DA-A4C6-06E3B5CDC14D</gtr:id><gtr:impact>Multidisciplinary grant application - obstetrics, midwifery, statistics, sociology</gtr:impact><gtr:outcomeId>CRx85zm7nTe-3</gtr:outcomeId><gtr:partnerContribution>Intellectual input</gtr:partnerContribution><gtr:piContribution>I initiated this collaboration to generate a proposal and later funding for a stillbirth prevention study</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Medical Detective Series</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>84F69B28-F69F-46D3-8D7F-B2CED1ED0808</gtr:id><gtr:impact>Audience of 100 members of the public who asked questions about research into preterm birth and its prevention.


The lecture is available on You Tube at http://www.youtube.com/watch?v=TC43j2UJ-GI&amp;amp;feature=player_embedded. As of Nov 2011 it has had 1400 hits on &amp;quot;You tube&amp;quot;.</gtr:impact><gtr:outcomeId>rpPwVCnqJDh</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Excesses of modern societies.  Optimal Pregnancy Environment Risk Assessment meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>96A8C32E-2A81-482F-923F-D17EF3B2F13F</gtr:id><gtr:impact>Risk assessment meeting</gtr:impact><gtr:outcomeId>56cb06c9bdcf84.54535171</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Inaugural lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5C4C154C-98FA-410C-885F-E051C9AAAA36</gtr:id><gtr:impact>120 attendees

Interest in research into preterm birth</gtr:impact><gtr:outcomeId>tGBkyJS8o7p</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>3.	Developmental Programming - Does it Really Exist? Evidence from Human Studies</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1E1E165E-CABE-4B77-900D-F9883C474EA0</gtr:id><gtr:impact>Developmental Programming Symposium at Society of Reproductive Investigation Meeting, San Francisco,</gtr:impact><gtr:outcomeId>56cb0789e852f2.71495301</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Improving outcomes for pregnant women and babies in Scotland through research. Scottish Government Maternity Services Good Practice Event Edinburgh, May 2014.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5CEAABDE-CC55-43FB-81CB-D17A569448A6</gtr:id><gtr:impact>Talk sparked questions and discussion afterwards

Talk sparked questions and discussion afterward</gtr:impact><gtr:outcomeId>55017dcb3496d6.99876344</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Multiple media references to EMPOWaR</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DCCA122E-47C1-4597-B9BF-C579E87B5EE1</gtr:id><gtr:impact>Multiple media references to EMPOWaR and discussion of issues of obesity in pregnancy. Article in Daily Telegraph, Daily Mail, New York times etc.

Increased awareness of the issues of maternal obesity</gtr:impact><gtr:outcomeId>h1mbNzBix7W</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article in Scotsman - Dieting, not eating for two 'benefits mother and baby'</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4066DF8F-E2F2-4509-A5D9-15A5306ED671</gtr:id><gtr:impact>Scotsman newspaper has large circulation list in Scotland

Increased public awareness of obesity in pregnancy issues</gtr:impact><gtr:outcomeId>MquCWPNS8cv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pint of Science Public Engagement Talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>787D5744-9F02-4800-900F-AE1260408996</gtr:id><gtr:impact>Pint of Science Talk &amp;quot;Sex Drugs and Birth&amp;quot; 23.5.16</gtr:impact><gtr:outcomeId>58bc63d91b44c1.76148342</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://pintofscience.co.uk/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Maternal and infant nutrition and health - Holyrood Magazine meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>19F10CB0-81DA-41DB-8210-537D646C4859</gtr:id><gtr:impact>Around 200 delegates, largely policy makers

Increased awareness of issues of maternal obesity</gtr:impact><gtr:outcomeId>Mdz8w8dNhdF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Articles about EMPOWaR study</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8BCB19ED-C3C0-463D-8DEF-BB660C75F17A</gtr:id><gtr:impact>Articles in the following papers and media outlets: 1/04/12: (The Daily Mail online) (The Herald Sun online (Australia) ) (Opposing Views online) (Christian Post online) (Active Quote) (Coventry Telegraph online) (Harborough Mail online) (Gather News online) (Halifax Courier online) (Skynews online) (The Herald) (The Star) (The Edinburgh Evening News) (The Daily Express) (Metro) (The Herald) (The Scotsman) (The Press and Journal) (Coventry Telegraph) (The Daily Telegraph) (The Daily Mail) (MedIndia online) (EsMas online) (Evening Herald online) (The Irish Independent) (Fox News online (USA)) (Magic Maman online) (Gulf News online ) (Perth Now) (News.com.au) (KSAZ-TV (Phoenix)) (Magic Maman online)

Increased public awareness of study</gtr:impact><gtr:outcomeId>EJuS3xYU5F7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>4.	Metformin in Obese Women in Pregnancy: results of the EMPOWaR study</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AB3AF143-0A3D-4DC5-B82A-EEAC8A307294</gtr:id><gtr:impact>Invited plenary lecture. British Maternal and Fetal Medicine Society annual meeting.</gtr:impact><gtr:outcomeId>56cb081b7041e3.39969130</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>An Odyssey in pregnancy research - there and back again. Inaugural Lecture, University of Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D69BD955-2FE7-44AC-B924-71B998CFA9C0</gtr:id><gtr:impact>Around 150 people attended this talk

Increased awareness of issues of maternal obesity</gtr:impact><gtr:outcomeId>d2jkNVAWZS8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>58000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Small project grant - The clinical and short term NHS cost of maternal obesity.</gtr:description><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:fundingRef>CZG/2/471 Denison</gtr:fundingRef><gtr:id>A3E8F08B-C506-4DBB-B7FB-53B982060020</gtr:id><gtr:outcomeId>WPTi25ZwWrk0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1327029</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>An open randomised trial of the Arabin pessary to prevent preterm birth in twin pregnancy - STOPPIT- 2.</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>5F66975F-C69D-4A9A-88DB-04BB21B87381</gtr:id><gtr:outcomeId>5457f386b555a1.92204342</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1494000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant - Poly(A)-binding proteins highlight the importance of regulated mRNA translation and stability in determining a functional materno-fetal interface.</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MRC MR/J003069/1</gtr:fundingRef><gtr:id>3B5566FD-928A-48A8-A179-DBA5BBC7B19D</gtr:id><gtr:outcomeId>UXD6pqNhcVe</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2050000</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:department>National Health and Medical Research Council</gtr:department><gtr:description>Should we treat iron deficiency anaemia of pregnancy with lactoferrin? A randomised controlled trial.</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Australian Government</gtr:fundingOrg><gtr:id>19FD9ADC-69FA-4BD3-9394-00345F2617A9</gtr:id><gtr:outcomeId>5457f27bd4b207.36330069</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre for Reproductive Health Centre grant</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1002033</gtr:fundingRef><gtr:id>6268B2CB-AFDD-49CD-B104-8B8F79F5A7AD</gtr:id><gtr:outcomeId>mTrWVgPse1V0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1090069</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>Suture Type for Incompetent Cervix and effect on Health outcomes</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>42A4FAFF-B2BC-4E85-A3FE-B94F96698726</gtr:id><gtr:outcomeId>5457f2b9ec0cf5.10202507</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1364000</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:department>National Health and Medical Research Council</gtr:department><gtr:description>My baby's movements study. NHMRC (Australia)</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Australian Government</gtr:fundingOrg><gtr:id>601736B7-E0FA-4DDF-B0D7-27828B536BE1</gtr:id><gtr:outcomeId>5457f2418a8066.40280100</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1756618</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>Effectiveness of progesterone to prevent miscarriage in women with early pregnancy bleeding: A randomised placebo-controlled trial (PRISM Trial</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>D560389D-DCB9-46AF-BF1D-013DF8262F35</gtr:id><gtr:outcomeId>5457f2f7e1b6e2.93513197</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1712000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>A pragmatic adaptive sequential placebo controlled randomised trial to determine the effectiveness of Glycerin trinitrate for retained placenta (Got-it trial).</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>F3027479-A504-4F7C-8DDB-D1947AB48F09</gtr:id><gtr:outcomeId>5457f1bde5c0e7.83750804</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Small project grant -Maternal obesity and programming of offspring obesity and cardiometabolic risk</gtr:description><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:fundingRef>CZG/2/478 (Reynolds)</gtr:fundingRef><gtr:id>B79355D9-3ED8-465A-8A75-7E4041D3A419</gtr:id><gtr:outcomeId>hy7cZRTkLwA0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>217000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Glibenclamide and metfoRmin versus stAndard Care in gEstational diabeteS (GRACES) - a feasibility open label randomised trial</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:id>1B1BF22C-A958-4F82-BAC8-CD9060DE3AFF</gtr:id><gtr:outcomeId>5457f2085a5ff7.59983816</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>240000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centre funding Tommys (charity)</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Guy?s &amp; St Thomas? Charity</gtr:fundingOrg><gtr:id>2EAA30A3-98FB-42BE-9E76-D295F0EB1A8C</gtr:id><gtr:outcomeId>MBqxtipgY8T0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Chief Scientist Office, Scottish Executive.</gtr:description><gtr:id>31E7D9FA-53F9-4888-8F0B-C724AFA73587</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>56c70109d973f1.06127086</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Glibenclamide and metfoRmin versus stAndard Care in gEstational diabeteS (GRACES) - a feasibility open label randomised trial</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:url>https://www.npeu.ox.ac.uk/graces</gtr:url><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Chief Scientist Office, Scottish Executive, (HSRC) and Sands</gtr:description><gtr:id>534D24A2-DD84-41EA-A501-C43D05942629</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>56c6ffe6964e39.75084761</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>AFFIRM - Does promoting increased awareness of decreased fetal movements reduce stillbirth, a stepped wedge cluster randomised trial?</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:url>http://www.crh.ed.ac.uk/affirm/</gtr:url><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Chief Scientist Office, Scottish Executive Funding</gtr:description><gtr:id>AA831A28-851B-4F0B-8C94-F86CDEA4FFB5</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>56c6fa17e62045.36219808</gtr:outcomeId><gtr:status>Under active development/distribution</gtr:status><gtr:title>STOPPIT baby follow up study: what effect does prophylactic progesterone in twin pregnancy have on childhood outcome?</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Use of metformin to reduce birthweight centile in obese pregnant women. Clinical trial called EMPOWaR funded by NIHR / EME
Clinical trial - ISRCTN51279843</gtr:description><gtr:id>CA32FA16-B19E-4E2B-B580-C8D7552BC7BF</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>cewViLxKKMs</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development_distribution</gtr:status><gtr:title>EMPOWaR</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:ukcrnIsctnId>ISRCTN51279843</gtr:ukcrnIsctnId><gtr:url>http://www.controlled-trials.com/ISRCTN51279843</gtr:url><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>National Institute of Health, Health Technology Assessment Board</gtr:description><gtr:id>05EFE7BC-3E4B-4781-A724-E3A902C95DC4</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>56c701ce239312.80149211</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>An open randomised trial of the Arabin pessary to prevent preterm birth in twin pregnancy - STOPPIT- 2.</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:url>https://w3.abdn.ac.uk/hsru/stoppit2/</gtr:url><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3703CC0A-2AE4-4F84-9EA1-6FC2567073D9</gtr:id><gtr:title>Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d56c77feaac3469d37bc80a2513e04d"><gtr:id>2d56c77feaac3469d37bc80a2513e04d</gtr:id><gtr:otherNames>Chiswick C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>56c5ed835da016.12109958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>513A1E0B-F2AC-4496-B06C-385196B5CAE2</gtr:id><gtr:title>Repeated weighing during pregnancy is ineffective in minimising maternal weight gain.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/638548bad142126ae84a2354ee6d05a5"><gtr:id>638548bad142126ae84a2354ee6d05a5</gtr:id><gtr:otherNames>Preston HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>56c704992be784.47014776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FB21F9A-467B-4768-BCED-E279A540996A</gtr:id><gtr:title>Efficacy of metformin in pregnant obese women: a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7490c73a69340d28c6adb50a04f35bb8"><gtr:id>7490c73a69340d28c6adb50a04f35bb8</gtr:id><gtr:otherNames>Chiswick CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>5501c6983a6aa2.19829638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>330C2AA4-E3D2-478E-8058-DD835326DCF1</gtr:id><gtr:title>Does metformin reduce excess birthweight in offspring of obese pregnant women? A randomised controlled trial of efficacy, exploration of mechanisms and evaluation of other pregnancy complications</gtr:title><gtr:parentPublicationTitle>Efficacy and Mechanism Evaluation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d56c77feaac3469d37bc80a2513e04d"><gtr:id>2d56c77feaac3469d37bc80a2513e04d</gtr:id><gtr:otherNames>Chiswick C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58b03d9bcb96c5.30168133</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_G1002463</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>